Skip to content

The Effect of Dilution and Prolonged Injection Time on Dexamethasone-induced Perineal Irritation

The Effect of Dilution With Glucose and Prolonged Injection Time on Dexamethasone-induced Perineal Irritation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04950049
Enrollment
200
Registered
2021-07-06
Start date
2021-07-15
Completion date
2021-08-31
Last updated
2021-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Effect

Keywords

Dexamethasone 21-phosphate, Pain, Pruritus, Glucose

Brief summary

The purpose of this study is to investigate the efficacy of dilution with glucose and prolonged injection time on dexamethasone 21-phosphate induced perineal irritation (include pian and pruritus).

Detailed description

Dexamethasone is a synthetic glucocorticoid, which may cause perineal irritation when given intravenously. The major clinical manifestations are pruritus and pain,and the incidence vary between 38%-71%. Some patients undergo spontaneous remission, while others develop into severe pain or pruritus. In clinical practice, dexamethasone is always diluted with glucose in many cases, but diluted dexamethasone in relieving dexamethasone induced perineal irritation has not been studied yet. The aim of this study was to investigate the efficacy of dilution with glucose on dexamethasone induced perineal irritation.

Interventions

DRUGDexamethasone

receive 2ml dexamethasone (5mg/ml)

OTHERDiluted dexamethasone 5ml

receive 5ml dexamethasone (2mg/ml) diluted with 5% glucose

OTHERDiluted dexamethasone 10ml

receive 10ml dexamethasone (1mg/ml) diluted with 5% glucose

OTHERDiluted dexamethasone 20ml

receive 20ml dexamethasone (0.5mg/ml) diluted with 5% glucose

Sponsors

General Hospital of Ningxia Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18-65 years * ASA physical status I-II

Exclusion criteria

* On regular use of analgesic * Contraindication or allergy to steroid or glucose * Drug or alcohol abuse * Diagnosed with paresthesia or mental diseases * Communication disorders * Pregnancy or nursing

Design outcomes

Primary

MeasureTime frameDescription
The incidence of dexamethasone-induced perineal irritationDuring the first 3 min period after the injection of dexamethasoneThe investigators record the number of cases of dexamethasone-induced perineal irritation (pain or pruritus) and calculate the incidence

Secondary

MeasureTime frameDescription
Duration of perineal irritationAfter the injection of dexamethasone, up to 5 minutesIf perineal irritation occurs, the investigators will record its duration
The severity of perineal irritationAfter the injection of dexamethasone, up to 5 minutesIf perineal irritation occurs, the investigators will assess its severity by using Visual Analogue Scale (the minimum is 0 and the maximum is 10, and the higher scores mean a worse outcome)

Contacts

Primary ContactHanxiang Ma
mahanxiang@hotmail.com+86-13519591508
Backup ContactYonghai Zhang
zhangyonghai826@aliyun.com+86-15909508072

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026